Tau Tangles in Parkinson’s Disease: A 2-Year Follow-Up Flortaucipir PET Study

Longitudinal tau PET in ageing and Alzheimer’s disease

(2018) Clifford R Jack et al.   BRAIN

18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal

(2018) Christopher M. Lee et al.   JOURNAL OF ALZHEIMERS DISEASE

The Value of In Vitro Binding as Predictor of In Vivo Results: A Case for [18F]FDDNP PET

(2018) Graham B. Cole et al.   MOLECULAR IMAGING AND BIOLOGY

Decreased noradrenaline transporter density in the motor cortex of Parkinson's disease patients

(2018) Michael Sommerauer et al.   MOVEMENT DISORDERS

Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease

(2018) Joseph R. Winer et al.   JAMA Neurology

18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies

(2018) Ruben Smith et al.   Scientific Reports

Off-Target18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation

(2017) Jae Yong Choi et al.   JOURNAL OF NUCLEAR MEDICINE

Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18

(2017) Michael D. Devous et al.   JOURNAL OF NUCLEAR MEDICINE

MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding

(2017) Allan K. Hansen et al.   MOLECULAR IMAGING AND BIOLOGY

Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases

(2017) Seung Ha Lee et al.   MOVEMENT DISORDERS

In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography

(2017) Allan K. Hansen et al.   MOVEMENT DISORDERS

The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases

(2017) Céline Vermeiren et al.   MOVEMENT DISORDERS

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain

(2017) Kok Pin Ng et al.   Alzheimers Research & Therapy

Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case

(2017) Marta Marquié et al.   Acta Neuropathologica Communications

Cortical laminar tau deposits and activated astrocytes in Alzheimer’s disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography

(2017) Laetitia Lemoine et al.   Scientific Reports

Characterization of tau positron emission tomography tracer [ 18 F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias

(2016) Kerstin Sander et al.   Alzheimers & Dementia

[F-18]AV-1451 positron emission tomography retention in choroid plexus: More than “off-target” binding

(2016) Milos D. Ikonomovic et al.   ANNALS OF NEUROLOGY

In vivoimaging of neuromelanin in Parkinson’s disease using18F-AV-1451 PET

(2016) Allan K. Hansen et al.   BRAIN

Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline

(2016) Stefan Sturm et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Tau PET in Alzheimer disease and mild cognitive impairment

(2016) Hanna Cho et al.   NEUROLOGY

PET Imaging of Tau Deposition in the Aging Human Brain

(2016) Michael Schöll et al.   NEURON

Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases

(2016) Stephen N. Gomperts et al.   JAMA Neurology

An autoradiographic evaluation of AV-1451 Tau PET in dementia

(2016) Val J. Lowe et al.   Acta Neuropathologica Communications

Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes

(2015) Lauren Walker et al.   ACTA NEUROPATHOLOGICA

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue

(2015) Marta Marquié et al.   ANNALS OF NEUROLOGY

Tau positron emission tomographic imaging in aging and early Alzheimer disease

(2015) Keith A. Johnson et al.   ANNALS OF NEUROLOGY

Tau imaging: early progress and future directions

(2015) Victor L Villemagne et al.   LANCET NEUROLOGY

Distribution of Monoamine Oxidase Proteins in Human Brain: Implications for Brain Imaging Studies

(2013) Junchao Tong et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Neuromelanin of the Human Substantia Nigra: An Update

(2013) Fabio A. Zucca et al.   NEUROTOXICITY RESEARCH

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases

(2013) Valeriy Duka et al.   PLoS One

Neuropathologic substrates of Parkinson disease dementia

(2012) David J. Irwin et al.   ANNALS OF NEUROLOGY

Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG

(2012) S. F. Carter et al.   JOURNAL OF NUCLEAR MEDICINE

Clinical progression in Parkinson disease and the neurobiology of axons

(2010) Hsiao-Chun Cheng et al.   ANNALS OF NEUROLOGY

New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals

(2008) L. Zecca et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA